1. Death after misuse of anabolic substances (clenbuterol, stanozolol and metandienone)
- Author
-
Andreas Thomas, Martin Juebner, Mario Thevis, Markus A. Rothschild, Sabrina Lehmann, Frank Glenewinkel, Hans Geyer, Karl-Heinz Schiwy-Bochat, and Hilke Andresen-Streichert
- Subjects
Adult ,Male ,medicine.medical_specialty ,Metandienone ,Poison control ,Autopsy ,Left ventricular hypertrophy ,01 natural sciences ,Clomiphene ,Pathology and Forensic Medicine ,03 medical and health sciences ,Anabolic Agents ,Fatal Outcome ,0302 clinical medicine ,Trenbolone ,Internal medicine ,medicine.artery ,Humans ,Medicine ,Clenbuterol ,Testosterone ,Androstanols ,030216 legal & forensic medicine ,Stanozolol ,Doping in Sports ,Heart Failure ,business.industry ,Methandrostenolone ,010401 analytical chemistry ,food and beverages ,medicine.disease ,Coronary Vessels ,0104 chemical sciences ,Endocrinology ,Right coronary artery ,Hypertrophy, Left Ventricular ,Trenbolone Acetate ,business ,Law ,medicine.drug - Abstract
A 34-year old male was found breathless and panting at home by his girlfriend three hours after a gym workout. Minutes later, he collapsed and died. Autopsy, histological and chemical analyses were conducted. The examination of the heart showed left ventricular hypertrophy, while the right coronary artery showed only a small vascular lumen (3 mm in diameter), due to its anatomical structure. In femoral blood concentrations of approx. 1 μg/L clenbuterol, approx. 56 μg/L stanozolol and approx. 8 μg/L metandienone, with trenbolone (limit of quantification (LOQ)) were detected. Additionally, there were positive results in urine for boldenone, clomiphene, trenbolone, metandienone, stanozolol, clenbuterol and drostanolone, along with indications of testosterone and/or testosterone prohormones having been taken. In consideration of all aspects of this case, in can be assumed that the long-term consumption of anabolic androgen steroids (AAS) caused apparently pathological changes of the heart. Over and above, the combination of anatomical (small lumed coronary artery, ventricular hypertrophy) and substance-induced risk factors led to the fatal cardiovascular failure.
- Published
- 2019
- Full Text
- View/download PDF